✦ LIBER ✦

PDB53 Cost-Effectiveness of Saxagliptin (Onglyza®) in Type 2 Diabetes in South Africa

✍ Scribed by A. Juarez-Garcia; D. Casalvolone; L. Qatami; K. Bergenheim; B.M.K. Donato

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of saxagliptin (Ongly

✍ Granström, Ola; Bergenheim, Klas; McEwan, Phil; Sennfält, Karin; Henriksson, Mar 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 602 KB

PDB45 COST-EFFECTIVENESS ANALYSIS OF SAX

✍ de Ramirez; A Arellano; M Brosa; J Franch; D Mauricio; C Alvarez; M Sanchez-Zamo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PDB9 Cost-Effectiveness Analysis of Saxa

✍ E.E. Arinina; M. Rashyd 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PDB37 THE COST-EFFECTIVENESS OF SAXAGLIP

✍ K Kolasa; M Niewada; J Puelles Fernandez de Troconiz; R Townsend; P McEwan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PDB44 THE COST-EFFECTIVENESS OF SAXAGLIP

✍ W Erhardt; K Bergenheim; R Townsend; J Puelles Fernandez de Troconiz; P McEwan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

PDB35 COST-EFFECTIVENESS ANALYSIS OF MET

✍ J Elgart; J Caporale; JJ Gagliardino; EC Aiello; M Waschbusch; L Jotimliansky 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB